Glycogen Storage Disease - 119 Studies Found
Completed |
: Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies :
|
Completed |
: Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease :
|
Approved for marketing |
: Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease :
|
Active, not recruiting |
: Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial :
|
Completed |
: Newborn Screening Assay of Pompe's Disease : Pompe Disease : 2008-07-09 : Other: Pompe disease newborn screening DBS will be tested for acid alpha-glucosidase (GAA)activity. Newb |
Terminated |
: Study to Evaluate the Safety of AT2220 in Pompe Disease : Pompe Disease : 2008-05-30 :
|
Completed |
: Safety and Efficacy of Clenbuterol on Motor Function in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy : Pompe Disease : 2013-09-11 :
|
Recruiting |
: A Long Term Follow up Study in Late-onset Pompe Disease : Pompe Disease : 2008-07-09 |
Recruiting |
: A Pilot Study of Pyridostigmine in Pompe Disease : Pompe Disease : 2015-01-23 : Drug: Pyridostigmine Bromide Pyridostigmine is an acetylcholinesterase inhibitor, which increases the am |